ZEB1 and ovarian cancer: We not only observed an increase in vimentin in the ovarian cancer cells in our study, but further confirmed the EMT induction through increase in another mesenchymal marker, ZEB1, with a simultaneous decrease in the epithelial marker, e-cadherin.